Posts Feed
Comments Feed

Committee Recommends FDA Approve Novel Anesthesia Drug To Reverse Muscle Relaxation Within Minutes

Schering-Plough (NYSE: SGP) announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval. After reviewing data on the safety and efficacy of the medication, the committee unanimously recommended approval of the company’s application for marketing.

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.